At present, vitiligo is the most common depigmenting skin disorder, characterized by clearly
demarcated discolored patches of various shapes and sizes. Depigmentation results from …

Aims and objectives The aim of this study is to systematically review randomized controlled
clinical trials (RCTs) studying various types of regenerative medicine methods (such as …

Background In 2015, a major achievement in vitiligo research was the development of an
internationally agreed upon core outcome domain set for randomized clinical trials (RCTs) …

Vitiligo is an autoimmune disease that leads to disfiguring depigmented lesions of skin and
mucosa. Although effective treatments are available for vitiligo, there are still some patients …

Background Vitiligo manifests as hypo‐to de‐pigmented macules, which are sometimes
associated with leukotrichia. For complete cosmetic improvement, the repigmentation of …

ABSTRACT Aims and Objectives The aim of this study is to examine the efficacy and safety
of various regenerative medicine treatments, such as cell therapy, platelet‐rich plasma …

ВВЕДЕНИЕ. Витилиго является приобретенным заболеванием кожи,
характеризующимся потерей пигментации с разрушением эпидермальных …

Background Transplantation plays a pivotal role in vitiligo surgery and has advanced at a
galloping pace. Objectives To enlist the latest developments in vitiligo transplantation …

Vitiligo é uma doença mucocutânea adquirida e despigmentante que se manifesta através
de máculas ou manchas acrômicas. Intervenções cirúrgicas no tratamento do vitiligo …

Table S4–Power calculations to determine the number of observations needed in WB and
SFD arms to detect a statistically significant difference of treatment effect for a VTE incidence …